Discontinuing Statins Linked to Cardiac Admissions in Elderly
FRIDAY, Aug. 2, 2019 -- For elderly patients taking statins for primary prevention, statin discontinuation is associated with an increased risk for admission for any cardiovascular event, according to a study published online July 30 in the European... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 2, 2019 Category: Pharmaceuticals Source Type: news

Heart attack: New study suggests stopping statins in old age raises risk by half
HEART ATTACK is a serious medical condition that can be brought on by underlying conditions. Recent evidence suggests stopping statins in old age can significantly raise the risk of an attack. (Source: Daily Express - Health)
Source: Daily Express - Health - July 31, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Stopping statins may increase cardiovascular risk
New research warns that stopping statin use later in life could significantly increase a person's risk of heart problems and vascular events. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 31, 2019 Category: Consumer Health News Tags: Statins Source Type: news

Stopping statins at 75 'raises the risk of a heart attack or stroke'
Scientists led by a hospital in Paris studied the medical records of 120,000 people and found those who stopped taking statins at 75 were also 26 per cent more likely to have a stroke. (Source: the Mail online | Health)
Source: the Mail online | Health - July 31, 2019 Category: Consumer Health News Source Type: news

NHS health checks reduce cardiovascular disease risk
People who had a health check were more likely to receive lifestyle advice and be prescribed statins Related items fromOnMedica Should we recognise obesity as a disease? Type 2 diabetes in 10 times more young people than realised More Scottish GPs needed to fight heart disease Diabetes will soon cost NHS £16.9bn Most supplements offer no real benefit, some might increase risks (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 31, 2019 Category: UK Health Source Type: news

Over-75s stopping statins face increased heart attack risk
Stopping statins raises heart attack risk by almost half for over 75s, researchers find Related items fromOnMedica Glucosamine supplements may reduce stroke risk Vitamin D supplements do not confer cardiovascular protection Gestational diabetes raises long-term CVD risk Coronary heart disease remains UK ’s biggest killer Heart disease and stroke deaths plummet in Scotland (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 31, 2019 Category: UK Health Source Type: news

Study: Level Of Healthcare After Heart Attack Varies By Region
BOSTON (CBS) — Where you live may influence the quality of healthcare you get after a heart attack, according to a study in JAMA Cardiology. After having a heart attack, patients should be treated with high-intensity statin therapy and drugs to lower cholesterol and try to prevent a second one. After studying data on nearly 140,000 patients hospitalized after a heart attack, researchers found large variations in high-intensity statin use across the country, with the greatest use in New England and lowest use in the west south-central region, which includes Texas and Louisiana. Statin use was also higher in teaching h...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 29, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated Local Dr. Mallika Marshall Heart Attack Source Type: news

Retiring CEO Bresch leaves a legacy of growth at Mylan
Global pharmaceutical company Mylan NV announced its CEO and Board Director Heather Bresch will retire as the company merges with Pfizer Inc. unit Upjohn by the middle of 2020 to form a new company with the EpiPen, Lipitor and Viagra among its products. In 2012, Bresch was the first woman named CEO of a Fortune 500 global pharmaceutical company. During an almost three-decade career at Mylan, she helped transform the company from a 300-employee, $100 million revenue, single-country operation into… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2019 Category: Pharmaceuticals Authors: Anne Stych Source Type: news

Exercise Performance and Muscle Strength in Statin Users Exercise Performance and Muscle Strength in Statin Users
A new study examines the question of whether statin-associated myalgia is associated with impaired aerobic exercise performance or muscle strength.Medicine and Science in Sports and Exercise (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 29, 2019 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Pfizer in talks to merge off-patent assets with Mylan
Deal would create large seller of drugs including former blockbuster brands Lipitor and Viagra (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 27, 2019 Category: Pharmaceuticals Source Type: news

Pfizer and Mylan in talks to merge off-patent drugs operations
Stock deal would create large seller of products including former blockbusters Lipitor and Viagra (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 27, 2019 Category: Pharmaceuticals Source Type: news

Pfizer and Mylan set to merge off-patent drugs operations
Stock deal will create large seller of products including former blockbusters Lipitor and Viagra (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 27, 2019 Category: Pharmaceuticals Source Type: news

Statin prescriptions following heart attacks differ by region of U.S.
Statin prescriptions for heart attack patients vary based on geographic location, a new study says, with the highest numbers found in the Northeast and lowest found in the South. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 25, 2019 Category: Consumer Health News Source Type: news

In Very Elderly, Intense Lipid-Lowering Worked in IMPROVE-IT In Very Elderly, Intense Lipid-Lowering Worked in IMPROVE-IT
The post-hoc analysis addresses a gap in the literature, said an expert observer: statin plus ezetimibe safely cut clinical risk in post-ACS patients aged> 75 compared with statin monotherapy.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 24, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Medical News Today: Everything you need to know about coming off statins
Statins are a type of medication that doctors prescribe to lower levels of 'bad' cholesterol and reduce the risks of heart attack and stroke. Learn how and why people stop taking statins here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 24, 2019 Category: Consumer Health News Tags: Statins Source Type: news

Health Insurers May Cover Statins, SSRIs, Inhalers and More at 100% Under Trump HDHP-HSA Notice
Here ’s the new list of what your health insurance plan might cover next year under Trump Treasury’s broadened definition of preventative care services. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 18, 2019 Category: Pharmaceuticals Authors: Ashlea Ebeling, Forbes Staff Source Type: news

One in 20 patients exposed to preventable harm in medical care
Nearly half of preventable patient harm was accounted for by drug-related incidents and other treatments Related items fromOnMedica MHRA tightens licence restrictions on valproate for women NI launches ‘One Health’ plan to tackle antimicrobial resistance Antibiotic scrip rates lower in CAM-trained practices GPs defend practice on prescribing statins NHS England in bid to cut drugs waste (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 18, 2019 Category: UK Health Source Type: news

Alirocumab Cuts CV Absolute Risk the Most for Those With Diabetes
TUESDAY, July 16, 2019 -- Among those receiving alirocumab in addition to statin therapy to reduce the risk for another cardiovascular event after a recent acute coronary syndrome, absolute risk reduction is greater for those with diabetes,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 16, 2019 Category: Pharmaceuticals Source Type: news

Cholesterol-lowering drugs under-prescribed for prevention of atherosclerotic cardiovascular disease
(Elsevier) Statins, the most commonly used effective lipid-lowering drugs, are significantly underutilized to treat lipid abnormalities in patients with and at risk for atherosclerotic cardiovascular disease (ASCVD), according to a retrospective study of more than 280,000 patients in Alberta, Canada. Investigators report in the Canadian Journal of Cardiology that only two-thirds of these patients were receiving moderate/high-intensity statins, and of the ones treated, more than a third are under-treated. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2019 Category: International Medicine & Public Health Source Type: news

We must revise drug regulatory framework at EU and national levels
More than half of new drugs entering the German healthcare system have not been shown to add benefit Related items fromOnMedica GPs defend practice on prescribing statins MHRA tightens licence restrictions on valproate for women Hunt announces Medicines and Medical Devices Safety Review Philip Morris knew nicotine is just one part of smoking addiction Antibiotics courses often longer than guidelines (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 12, 2019 Category: UK Health Source Type: news

Memory is impaired by prescription blood pressure meds, but pomegranate juice improves blood pressure and cognitive function
(Natural News) Struggling to find clinical benefits for statin drugs and blood pressure medications, a team of researchers put two drug protocols to the test to see their effects on human thinking and memory. The research, funded by the maker of the drugs (AstraZeneca), hoped to find cognitive benefits for candesartan and hydrocholorothiazide, rosuvastatin, or... (Source: NaturalNews.com)
Source: NaturalNews.com - July 10, 2019 Category: Consumer Health News Source Type: news

Non-HDL Cholesterol a CV-Risk Crystal Ball for Young Adults Non-HDL Cholesterol a CV-Risk Crystal Ball for Young Adults
High levels at age 25 – 40 are likely to persist decades later, and indeed they predicted risk for cardiovascular disease. Are some young adults better candidates for statins than usually thought?Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 10, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

pravastatin (Pravichol)
Title: pravastatin (Pravichol)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/10/2019 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - July 10, 2019 Category: Cardiology Source Type: news

' Negative Risk Markers' Seen to Sharpen Targeting of Statins'Negative Risk Markers' Seen to Sharpen Targeting of Statins
Low coronary artery calcium scores and other markers of low risk could help individualize guideline-based risk predictions; fewer elderly people could be targeted for preventive statins.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 4, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Men ’s dementia risk higher after androgen deprivation therapy
Carefully weigh benefits of hormone suppression against risks for men with prolonged life expectancy Related items fromOnMedica Fund specialist dementia training to improve care and save money New evidence on benzodiazepine link to Alzheimer ’s Statin use after stroke not linked to bleeds Some antipsychotics linked to raised mortality in dementia One in 10 children in phase I cancer trials respond to drugs (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 4, 2019 Category: UK Health Source Type: news

Statin Use Associated With Higher Incidence of Diabetes
TUESDAY, July 2, 2019 -- There may be a dose-dependent relationship between statin therapy and new-onset diabetes across the duration of statin use, according to a study recently published in Diabetes Metabolism Research and Reviews. Victoria A.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 2, 2019 Category: Pharmaceuticals Source Type: news

Statin Use Postadiation Tied to Significant Stroke Reduction Statin Use Postadiation Tied to Significant Stroke Reduction
Retrospective data show a 32% reduction in stroke and nonsignificant 15% reduction in cardiovascular and cerebrovascular events with postradiation statin therapy for thorax or head or neck cancer.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 1, 2019 Category: Neurology Tags: Cardiology News Source Type: news

Statin Use Postradiation Tied to Significant Stroke Reduction Statin Use Postradiation Tied to Significant Stroke Reduction
Retrospective data show a 32% reduction in stroke and nonsignificant 15% reduction in cardiovascular and cerebrovascular events with postradiation statin therapy for thorax or head or neck cancer.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - July 1, 2019 Category: Intensive Care Tags: Cardiology News Source Type: news

Adding non-statin agents for CVD prevention too costly in Thailand
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2019 Category: Drugs & Pharmacology Source Type: news

Statin use reduces mortality and stroke risk in dementia patients, new study shows
(Spink Health) The study, which analyzed 44,920 Swedish dementia patients from the Swedish Dementia Registry between 2008-2015, found users of statins had a 22% lower risk of all-cause death compared to matched non-users. The research also demonstrated that statin users had a 23% reduction in the risk of stroke, which is three times more likely in patients with mild dementia and seven times more likely in those with severe dementia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 30, 2019 Category: International Medicine & Public Health Source Type: news

FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs
The U.S. Food and Drug Administration (FDA) has approved important safety label changes for the class of cholesterol-lowering drugs known as statins. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 26, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Medical News Today: Statins may double the risk of type 2 diabetes
New research examines the risk of receiving a type 2 diabetes diagnosis among those who are taking statins to lower their cholesterol. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 26, 2019 Category: Consumer Health News Tags: Diabetes Type 2 Source Type: news

Statins May Cut Stroke Risk After Cancer Radiation
Radiation therapy can cause arteries to scar or thicken, leading to blockages that can result in heart attacks and strokes. Statins work by keeping plaques from building up in blood vessels, preventing blockages. (Source: WebMD Health)
Source: WebMD Health - June 20, 2019 Category: Consumer Health News Source Type: news

Statins May Lower Risk of Stroke After Cancer Radiotherapy
Title: Statins May Lower Risk of Stroke After Cancer RadiotherapyCategory: Health NewsCreated: 6/19/2019 12:00:00 AMLast Editorial Review: 6/20/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 20, 2019 Category: Cardiology Source Type: news

Vitamin D supplements do not confer cardiovascular protection
Supplementation not associated with reduced risks of CVD events or all-cause mortality in meta-analysis Related items fromOnMedica Coronary heart disease remains UK ’s biggest killer NICE says far more people should take statins Type 2 diabetes in 10 times more young people than realised Sugar not saturated fat is the major issue for CVD Physical activity might offset harms of time spent sitting (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 20, 2019 Category: UK Health Source Type: news

Statins could cut heart risk for many more Britons, study suggests
DNA tests might identify ‘invisible population’ who are not currently seen as in dangerHundreds of thousands more adults in the UK could benefit from taking statins because their genes put them at high risk of heart disease, research suggests.Speaking on Wednesday at the UK Biobank conference in London, Prof Sir Peter Donnelly, the founder of the company Genomics Plc, warned of an “invisible population” who are not identified as at risk by current screening programmes because their blood pressure and cholesterol do not raise red flags.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 19, 2019 Category: Science Authors: Hannah Devlin Science correspondent Tags: Medical research Heart disease Health Heart attack Science Society UK news Source Type: news

Study: Statins reduce stroke risk for cancer patients who received radiation
Cancer patients who took statins to lower cholesterol after radiation treatment for the chest, head or neck saw their stroke risk fall by 32 percent (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 19, 2019 Category: Consumer Health News Source Type: news

Statins May Be Beneficial After Radiation to Thorax, Head, Neck
Statin use tied to reduction in stroke incidence for cardiac patients with thorax and head or neck cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 19, 2019 Category: Cancer & Oncology Tags: Cardiology, Oncology, Pharmacy, Radiology, Journal, Source Type: news

Statins May Lower Risk of Stroke After Cancer Radiotherapy
WEDNESDAY, June 19, 2019 -- Radiation treatment for cancer can damage the heart and blood vessels, increasing the risk for a stroke or heart attack. But a new study suggests cholesterol-lowering drugs can significantly reduce that risk. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 19, 2019 Category: General Medicine Source Type: news

Statins May Be Beneficial After Radiation to Thorax, Head, Neck
WEDNESDAY, June 19, 2019 -- For cardiac patients with thorax and head or neck cancer, statin use after radiation therapy is associated with a significant reduction in stroke incidence and a trend toward reduced cardiovascular and cerebrovascular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 19, 2019 Category: Pharmaceuticals Source Type: news

Statins May Lower Risk of Stroke After Cancer Radiotherapy
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - June 19, 2019 Category: Cancer & Oncology Source Type: news

How thousands of British patients may have taken tainted NHS drugs sold by the mafia
Commonly prescribed drugs were stolen in Italy and then sold to British pharmacists and hospitals, exposing patients to potentially lethal consequences. Among them is statin rosuvastatin. (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2019 Category: Consumer Health News Source Type: news

National Diabetes Audit
This report examines the findings from the 2017-18 audit. It contains the full key findings, recommendations and new analysis relating to cardiovascular disease (CVD) risk, including new treatment targets showing statin prescriptions for CVD risk reduction (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 14, 2019 Category: Consumer Health News Source Type: news

More Aggressive Statin Tx Needed After Heart Attack in Young Patients
FRIDAY, June 14, 2019 -- The majority of young heart attack patients with familial hypercholesterolemia (FH) still have elevated cholesterol levels a year later, according to a study published in the May 21 issue of the Journal of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2019 Category: Pharmaceuticals Source Type: news

Lowering cholesterol is not enough to reduce hyperactivity of the immune system
(Radboud University Medical Center) Despite treatment with statins, many patients with elevated cholesterol levels will still develop cardiovascular disease. It is apparent that not only cholesterol but also the immune system plays an important role in the development of atherosclerosis. Researchers from the Netherlands now provide a novel potential explanation for this residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2019 Category: International Medicine & Public Health Source Type: news

Diabetes drug cuts cardiovascular and kidney problems
Large international study explores role of dulaglutide Related items fromOnMedica Statin use link to heightened type 2 diabetes risk in some people Diabetes prescriptions rise by a third in last five years US expert group updates statins recommendations Drug could cut heart events by 26% in diabetics Metformin doesn ’t help HbA1c in teens with type 1 diabetes (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 10, 2019 Category: UK Health Source Type: news

Immunotherapy delays type 1 diabetes, study finds
Drug delays diabetes onset a median of 2 years Related items fromOnMedica Statin use link to heightened type 2 diabetes risk in some people Type 2 diabetes drugs vary in impact on survival NICE approves extra ‘triple therapy’ drug for diabetes Study claims medical treatment can reverse type 2 diabetes Drug could cut heart events by 26% in diabetics (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 10, 2019 Category: UK Health Source Type: news

DR MICHAEL MOSLEY: It's not statins giving you aches and pains, it's the 'nocebo' effect
Dr Michael Mosley takes a look at the nocebo effect and why many people are giving up statins medication. (Source: the Mail online | Health)
Source: the Mail online | Health - June 8, 2019 Category: Consumer Health News Source Type: news

Model Explores How Statins Alter Multiple Sclerosis Outcomes
FRIDAY, June 7, 2019 -- Simvastatin's beneficial effects on clinical outcomes and brain atrophy in patients with multiple sclerosis (MS) are largely independent of cholesterol levels, according to a post hoc study published in the May 28 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2019 Category: Pharmaceuticals Source Type: news

CAD software helps stratify risk in lung cancer patients
By measuring the percentage of pulmonary fibrosis on CT exams in lung cancer...Read more on AuntMinnie.comRelated Reading: Risk models boost efficiency of CT lung cancer screening AI predicts lung cancer survival from CT scan data AI reliably characterizes pulmonary nodules on CT Lung abnormalities at CT linked to in-hospital death CT shows link between statins and lung abnormalities in smokers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 6, 2019 Category: Radiology Source Type: news